GO:0001730 2'-5'-oligoadenylate synthetase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001730 describes the enzymatic activity that polymerizes ATP into 2'-5'-linked oligoadenylates (2-5A) in a double-stranded RNA-dependent manner.
• 2-5A acts as a second messenger that activates RNase L, leading to degradation of viral and cellular RNA and inhibition of protein synthesis.
• The OAS family includes OAS1, OAS2, OAS3, and OASL, with OAS1 being the most extensively studied for its antiviral and immunomodulatory roles [1,3].
• OAS activity is regulated by dsRNA binding, divalent metal ions, and specific RNA sequence motifs, and is inhibited by 2'-phosphodiesterase [2,5,8].
• Dysregulation of OAS enzymes is linked to viral susceptibility, cancer, and autoimmune diseases, making them attractive therapeutic targets [1,4].
• CRISPR-based knockout, knock-in, and overexpression models are essential for dissecting OAS gene function and developing targeted therapies [1,3].
Description
The 2'-5'-oligoadenylate synthetase (OAS) family of enzymes catalyzes the synthesis of 2'-5'-linked oligoadenylates (2-5A) from ATP in a reaction that requires double-stranded RNA (dsRNA) as a cofactor. This activity, annotated as GO:0001730, is a cornerstone of the innate immune response to viral infection, as the 2-5A products activate the latent endoribonuclease RNase L, which degrades viral and cellular RNAs and thereby restricts viral replication. The OAS/RNase L pathway is one of the best-characterized antiviral effector systems in mammals, and its importance extends beyond antiviral defense to roles in cell growth, differentiation, and apoptosis. Researchers studying host-pathogen interactions, interferon signaling, and RNA biology frequently encounter OAS enzymes, making a clear understanding of GO:0001730 essential for experimental design and data interpretation. The activity is conserved across metazoans, from sponges to humans, underscoring its fundamental biological significance. In this article, we provide a comprehensive overview of the molecular mechanism, key genes, regulatory features, disease associations, and research methodologies related to 2'-5'-oligoadenylate synthetase activity, with a focus on how CRISPR-based models can accelerate discovery.
2'-5'-oligoadenylate synthetase activity At A Glance
| GO ID | GO:0001730 |
|---|---|
| GO term | 2'-5'-oligoadenylate synthetase activity |
| Ontology | molecular_function |
| Synonym | 2-5A synthetase activity; 2'-5' oligoadenylate synthetase activity; (2-5')oligo(A) synthetase activity; oligo-2',5'-adenylate synthetase activity |
| Major function | Synthesis of 2'-5'-linked oligoadenylates from ATP in a dsRNA-dependent manner |
| Cofactor | Double-stranded RNA |
| Reaction | ATP = pppA(2'p5'A)n oligomers |
| Regulation | Inhibited by divalent metal ions; modulated by specific RNA sequence motifs; degraded by 2'-phosphodiesterase |
What Is GO:0001730?
2'-5'-oligoadenylate synthetase activity (GO:0001730) is defined as the catalysis of the reaction: ATP = pppA(2'p5'A)n oligomers, which requires the binding of double-stranded RNA. In other words, it is the enzymatic activity that converts ATP into short polymers of adenosine linked by 2'-5' phosphodiester bonds, a process that is triggered when the enzyme binds to dsRNA. This activity is a molecular function, and it is the defining biochemical property of the OAS family of proteins.
Why Is 2'-5'-oligoadenylate synthetase activity Important in Cell Biology?
2'-5'-oligoadenylate synthetase activity is a central component of the innate antiviral response, as it initiates a signaling cascade that culminates in RNase L activation and RNA degradation. This pathway is critical for controlling a wide range of viral infections, and genetic variations in OAS genes have been associated with differential susceptibility to viral diseases [1,3]. Beyond antiviral defense, OAS enzymes influence cell proliferation, apoptosis, and immune regulation, and their dysregulation has been implicated in cancer and autoimmune disorders [1,4]. Understanding the molecular details of GO:0001730 is therefore essential for developing antiviral therapies, cancer immunotherapies, and for interpreting genome-wide association studies that link OAS polymorphisms to human disease.
• OAS enzymes are key effectors of interferon-mediated antiviral immunity.
• 2-5A activates RNase L, leading to degradation of viral and cellular RNA.
• OAS1 polymorphisms are associated with susceptibility to viral infections and cancer [1,3].
• OAS2 inhibits Zika virus replication through activation of type I IFN signaling.
• OAS activity is conserved from sponges to humans, indicating fundamental biological roles.
• Divalent metal ions inhibit OAS activity, providing a regulatory mechanism.
• Specific RNA sequence motifs can activate OAS, linking RNA sequence to immune sensing.
• OASL and other family members have ubiquitin-like domains with distinct functions.
• Duck, goose, and ostrich OAS enzymes show species-specific antiviral activities.
• Targeting OAS enzymes with CRISPR models can reveal causal roles in disease [1,3].
What Happens During 2'-5'-oligoadenylate synthetase activity?
Double-stranded RNA binding and activation
In simple terms: The enzyme must first grab onto double-stranded RNA to become active.
OAS enzymes are inactive until they bind to double-stranded RNA (dsRNA), which serves as a cofactor and allosteric activator. This binding induces a conformational change that enables the enzyme to catalyze the polymerization of ATP into 2'-5'-linked oligoadenylates. The requirement for dsRNA ensures that OAS is activated primarily in the presence of viral replication intermediates or other dsRNA species, providing a mechanism for pathogen discrimination. Specific RNA sequence motifs can enhance OAS activation, as shown by Kodym et al..
Synthesis of 2'-5'-oligoadenylates (2-5A)
In simple terms: The active enzyme strings together ATP molecules into short chains with unusual 2'-5' links.
Once activated, OAS catalyzes the transfer of AMP moieties from ATP to the 2'-hydroxyl group of an acceptor adenosine, forming 2'-5' phosphodiester bonds. The reaction produces a mixture of oligomers with the general structure pppA(2'p5'A)n, where n can vary from 1 to several units. These 2-5A molecules are the primary products of GO:0001730 and act as second messengers.
Activation of RNase L and RNA degradation
In simple terms: The 2-5A chains act as alarm signals that switch on a destructive enzyme called RNase L.
The 2-5A oligomers bind to and activate RNase L, a latent endoribonuclease. Activated RNase L then cleaves single-stranded RNA at UU and UA dinucleotide sequences, leading to degradation of viral and cellular RNAs and inhibition of protein synthesis. This cascade is a major antiviral effector pathway and is also involved in apoptosis and cell growth regulation.
Degradation of 2-5A by 2'-phosphodiesterase
In simple terms: The alarm signal is eventually switched off by an enzyme that chews up the 2-5A chains.
To prevent excessive RNA degradation, 2-5A is rapidly degraded by 2'-phosphodiesterase, which cleaves the 2'-5' linkages. This enzyme activity has been found even in the lowest metazoans, such as sponges, indicating an ancient regulatory mechanism. The balance between OAS synthesis and 2'-phosphodiesterase degradation controls the intensity and duration of the RNase L response.
Inhibition by divalent metal ions
In simple terms: Certain metal ions can put a brake on the enzyme's activity.
Divalent metal ions such as calcium and zinc inhibit 2'-5'-oligoadenylate synthetase activity. This inhibition may serve as a regulatory mechanism to modulate the pathway under different physiological conditions. Researchers should consider metal ion concentrations when assaying OAS activity in vitro.
Key Genes Involved in GO:0001730 2'-5'-oligoadenylate synthetase activity
The following genes encode proteins with 2'-5'-oligoadenylate synthetase activity or directly regulate this activity, and they are frequently studied in antiviral and cancer research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| OAS1 | Catalyzes 2-5A synthesis; key antiviral effector | Most studied OAS family member; polymorphisms linked to viral susceptibility and cancer [1,3] |
| OAS2 | Catalyzes 2-5A synthesis; inhibits Zika virus | Involved in type I IFN signaling and antiviral defense |
| OAS3 | Catalyzes 2-5A synthesis; contributes to antiviral response | Less characterized but important for full antiviral activity |
| OASL | Contains ubiquitin-like domains; may have regulatory roles | Distinct from other OAS enzymes; involved in immune modulation |
| RNASEL | Endoribonuclease activated by 2-5A | Mediates RNA degradation and apoptosis; linked to cancer |
| 2'-PDE | Degrades 2-5A, terminating the signal | Regulates the duration of RNase L activation |
| IFIH1 (MDA5) | Cytosolic dsRNA sensor that induces IFN and OAS | Upstream regulator of OAS expression |
| DDX58 (RIG-I) | Cytosolic dsRNA sensor that induces IFN and OAS | Upstream regulator of OAS expression |
| IRF3 | Transcription factor for IFN and ISGs including OAS | Controls OAS gene expression |
| STAT1 | Transcription factor for IFN-stimulated genes | Mediates IFN-induced OAS expression |
| JAK1 | Kinase in IFN signaling pathway | Required for OAS induction |
| JAK2 | Kinase in IFN signaling pathway | Required for OAS induction |
| TYK2 | Kinase in IFN signaling pathway | Required for OAS induction |
| IFNAR1 | Type I IFN receptor subunit | Initiates signaling that leads to OAS expression |
| IFNAR2 | Type I IFN receptor subunit | Initiates signaling that leads to OAS expression |
| OAS1 (mouse paralogs) | Mouse Oas1 paralogs have distinct antiviral specificities | Model for studying OAS gene family evolution and function |
| OAS (duck/goose/ostrich) | Avian OAS enzymes show species-specific activities | Comparative studies of antiviral defense |
How Is 2'-5'-oligoadenylate synthetase activity Regulated?
The expression of OAS genes is primarily regulated by interferons (IFNs) through the JAK-STAT signaling pathway. Upon IFN binding to its receptor, JAK kinases activate STAT transcription factors, which translocate to the nucleus and induce transcription of IFN-stimulated genes, including OAS1, OAS2, OAS3, and OASL. At the protein level, OAS activity is regulated by dsRNA binding, which is required for activation, and by divalent metal ions, which inhibit the enzyme [1,8]. Additionally, specific RNA sequence motifs can modulate OAS activation, and 2'-phosphodiesterase degrades the 2-5A products to terminate signaling [2,5]. This multi-layered regulation ensures that the OAS/RNase L pathway is tightly controlled to avoid excessive RNA degradation and cell death.
2'-5'-oligoadenylate synthetase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| OAS1 | Viral susceptibility, cancer | Knockout and overexpression cell lines [1,3] |
| OAS2 | Zika virus infection | Knockout and overexpression cell lines |
| RNASEL | Prostate cancer, antiviral defense | Knockout mouse models |
| OASL | Immune regulation | Knock-in and knockout models |
| 2'-PDE | Regulation of RNase L pathway | Overexpression and knockout models |
Viral infections
OAS enzymes are critical for controlling viral infections, and genetic variations in OAS genes have been associated with differential susceptibility to viruses such as Zika, influenza, and SARS-CoV-2 [1,4]. OAS2 specifically inhibits Zika virus replication through activation of type I IFN signaling. Mouse Oas1 paralogs exhibit distinct antiviral activities, highlighting the importance of species-specific studies. Avian OAS enzymes from ducks, geese, and ostriches also show antiviral functions, suggesting conserved roles across species.
Cancer
The OAS/RNase L pathway has been implicated in cancer biology, with RNase L acting as a tumor suppressor in some contexts. Polymorphisms in OAS1 and RNASEL have been linked to prostate cancer risk, and OAS enzymes may influence cell proliferation and apoptosis. The balance between OAS activity and 2'-phosphodiesterase degradation may affect cancer cell survival.
Autoimmune and inflammatory diseases
Dysregulated OAS activity can contribute to autoimmune and inflammatory conditions due to excessive RNA degradation and immune activation. The OAS/RNase L pathway is also involved in the pathogenesis of Aicardi-Goutières syndrome and other interferonopathies. Understanding how OAS activity is regulated may provide therapeutic targets for these diseases.
From 2'-5'-oligoadenylate synthetase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does OAS1 mediate antiviral defense against a specific virus? | OAS1 knockout cell lines (e.g., A549, HEK293) |
| What is the effect of a disease-associated OAS1 polymorphism? | Point mutation knock-in cell lines |
| How does OAS2 contribute to Zika virus restriction? | OAS2 overexpression and knockout cells |
| What is the role of OASL ubiquitin-like domains? | Domain-specific knock-in and knockout models |
| How does 2'-phosphodiesterase regulate 2-5A levels? | 2'-PDE overexpression and knockout cells |
| Can OAS activity be modulated by metal ions? | In vitro enzymatic assays with metal ion treatments |
How to Study the 2'-5'-oligoadenylate synthetase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro OAS activity assay | Conversion of ATP to 2-5A | Enzyme kinetics and inhibitor testing [1,5] |
| RNA-seq | Expression of OAS and ISGs | Antiviral response profiling |
| Western blot | OAS protein levels | Validation of knockout or overexpression |
| CRISPR knockout screen | Genes affecting OAS pathway | Discovery of novel regulators |
| Mass spectrometry | OAS interacting proteins | Identification of complexes |
| Immunofluorescence | Subcellular localization of OAS | Visualization of dsRNA binding |
| qRT-PCR | OAS mRNA levels | Rapid quantification of gene expression |
| RNase L activity assay | RNA degradation | Functional readout of OAS pathway |
Enzymatic activity assays
2'-5'-oligoadenylate synthetase activity can be measured in vitro by incubating cell lysates or purified enzyme with ATP and dsRNA, followed by separation and quantification of 2-5A products using thin-layer chromatography or HPLC [1,5]. These assays are essential for confirming the biochemical function of OAS enzymes and for testing inhibitors or activators.
RNA-seq and transcriptomics
RNA sequencing can be used to measure the expression of OAS genes and other interferon-stimulated genes in response to viral infection or IFN treatment. Transcriptomic profiling helps identify the broader regulatory network and potential feedback mechanisms involving OAS activity.
Proteomics and immunoblotting
Western blotting and mass spectrometry can detect OAS protein levels and post-translational modifications. Proteomic approaches can identify interacting partners of OAS enzymes and downstream effectors such as RNase L.
CRISPR screening
Genome-wide CRISPR knockout screens can identify genes that modulate OAS activity or the OAS/RNase L pathway, revealing novel regulators and potential therapeutic targets. Such screens are particularly useful for uncovering host factors that affect viral replication in an OAS-dependent manner.
How CRISPR Can Be Used to Study GO:0001730 2'-5'-oligoadenylate synthetase activity
Knockout
CRISPR knockout of OAS genes (e.g., OAS1, OAS2, OAS3) in cell lines such as A549 or HEK293 can abolish 2'-5'-oligoadenylate synthetase activity, allowing researchers to test the specific contribution of each gene to antiviral defense and other cellular processes [1,3]. Knockout models are also useful for validating antibody specificity and for identifying compensatory mechanisms.
Point Mutation
CRISPR-mediated point mutations can introduce disease-associated polymorphisms (e.g., OAS1 variants) into the endogenous locus, enabling precise functional studies of how single amino acid changes affect enzymatic activity, dsRNA binding, and antiviral capacity. Such models are valuable for personalized medicine approaches.
Knock-in
Knock-in of tagged OAS genes (e.g., FLAG or GFP) allows for affinity purification, imaging, and proteomic analysis of OAS complexes in their native context. Knock-in of reporter genes under the OAS promoter can be used to monitor OAS expression in real time.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of OAS genes can be used to study gain-of-function effects, including enhanced antiviral activity and potential toxicity from excessive RNA degradation [1,4]. Overexpression models are particularly useful for testing the antiviral spectrum of different OAS enzymes.
How EDITGENE Supports 2'-5'-oligoadenylate synthetase activity Research
Researchers studying 2'-5'-oligoadenylate synthetase activity-related genes often need to determine whether a candidate gene is causally involved in antiviral defense, cancer, or immune regulation. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation and accelerating therapeutic discovery.
Contact EDITGENE today to design your custom CRISPR model for 2'-5'-oligoadenylate synthetase activity research.
Frequently Asked Questions About 2'-5'-oligoadenylate synthetase activity
What is 2'-5'-oligoadenylate synthetase activity?
It is the enzymatic activity (GO:0001730) that synthesizes 2'-5'-linked oligoadenylates from ATP in a double-stranded RNA-dependent manner, a key step in antiviral defense.
What genes are involved in 2'-5'-oligoadenylate synthetase activity?
The main genes are OAS1, OAS2, OAS3, and OASL, which encode enzymes with this activity, as well as downstream effectors like RNase L [1,7].
How is 2'-5'-oligoadenylate synthetase activity regulated?
It is activated by double-stranded RNA and inhibited by divalent metal ions; expression is induced by interferons through the JAK-STAT pathway [1,8].
What diseases are associated with OAS enzymes?
OAS enzymes are linked to viral infections (e.g., Zika, influenza), cancer, and autoimmune conditions such as Aicardi-Goutières syndrome [1,4].
What is the role of 2-5A in the immune response?
2-5A acts as a second messenger that activates RNase L, leading to degradation of viral RNA and inhibition of protein synthesis.
Can CRISPR be used to study 2'-5'-oligoadenylate synthetase activity?
Yes, CRISPR knockout, knock-in, and overexpression models are powerful tools to dissect the function of OAS genes and their role in disease [1,3].
What is the difference between OAS1, OAS2, and OAS3?
They are distinct enzymes with varying affinities for dsRNA and different antiviral specificities; OAS1 is the most studied, while OAS2 has been shown to inhibit Zika virus [1,4].
How is OAS activity measured in the lab?
It is typically measured by in vitro assays that detect the conversion of ATP to 2-5A using chromatography or HPLC [1,5].
What is the evolutionary origin of 2'-5'-oligoadenylate synthetase activity?
The activity is ancient, having been found in the lowest metazoans such as sponges, indicating a fundamental role in immunity.
Are there species-specific differences in OAS enzymes?
Yes, studies in ducks, geese, and ostriches have shown species-specific antiviral activities, and mouse Oas1 paralogs exhibit distinct functions [3,6].
Conclusion
2'-5'-oligoadenylate synthetase activity (GO:0001730) is a fundamental enzymatic function in innate immunity, responsible for producing 2-5A second messengers that activate RNase L and degrade RNA. Its importance spans antiviral defense, cancer, and autoimmune diseases, and its regulation is tightly controlled by dsRNA, metal ions, and degradation enzymes. CRISPR-based models are indispensable for dissecting the specific roles of OAS family members and for developing targeted therapies. EDITGENE's comprehensive services empower researchers to generate precise knockout, knock-in, and overexpression models, accelerating discoveries in this vital pathway.
References
- 1. Schwartz SL et al.. 2019. RNA regulation of the antiviral protein 2'-5'-oligoadenylate synthetase.. Wiley Interdiscip Rev RNA 10(4):e1534 PMID: 30989826
- 2. Saby E et al.. 2009. 2'-phosphodiesterase and 2',5'-oligoadenylate synthetase activities in the lowest metazoans, sponge [porifera].. Biochimie 91(11-12):1531-4 PMID: 19665065
- 3. Elkhateeb E et al.. 2016. The role of mouse 2',5'-oligoadenylate synthetase 1 paralogs.. Infect Genet Evol 45:393-401 PMID: 27663720
- 4. Liao X et al.. 2020. 2', 5'-Oligoadenylate Synthetase 2 (OAS2) Inhibits Zika Virus Replication through Activation of Type Ι IFN Signaling Pathway.. Viruses 12(4) PMID: 32276512
- 5. Kodym R et al.. 2009. 2'-5'-Oligoadenylate synthetase is activated by a specific RNA sequence motif.. Biochem Biophys Res Commun 388(2):317-22 PMID: 19665006
- 6. Tag-El-Din-Hassan HT et al.. 2018. Functional analysis of duck, goose, and ostrich 2'-5'-oligoadenylate synthetase.. Infect Genet Evol 62:220-232 PMID: 29715528
- 7. Eskildsen S et al.. 2003. Characterization of the 2'-5'-oligoadenylate synthetase ubiquitin-like family.. Nucleic Acids Res 31(12):3166-73 PMID: 12799444
- 8. Hartmann R et al.. 2001. Inhibition of 2'-5' oligoadenylate synthetase by divalent metal ions.. FEBS Lett 507(1):54-8 PMID: 11682059
